Brevan Howard Capital Management’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Brevan Howard Capital Management's ACLS Position: Q2 2026 in Review
Brevan Howard Capital Management increased its Axcelis (ACLS) stake by 38% in Q2 2026, buying an estimated $211K and bringing the position to 5,207 shares worth $986K. The position accounts for 0.01% of the portfolio, ranked #1066.
Brevan Howard Capital Management first reported a position in ACLS in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.32M in Q3 2024. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Brevan Howard Capital Management held 5,207 shares of Axcelis worth $986K as of Q2 2026.
- Brevan Howard Capital Management bought 1,423 Axcelis shares in Q2 2026, an estimated $211K.
- Axcelis made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1066 holding.
- Brevan Howard Capital Management first reported a position in Axcelis in Q4 2023 and has held it in 9 quarters since.
- Brevan Howard Capital Management's Axcelis position peaked at $2.32M in Q3 2024.
- 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.